Prescriptions were filled with an average turnaround time of 2.2 days, and 95.5% of approved medications were filled in a timely manner to help adherence
The S2 category covers GHRH analogs as a whole, and the prohibition applies regardless of the FDA-approved or Health Canada-approved status of the substance for the HIV-lipodystrophy indication
[1] Unlike amphetamine abuse, where drug tolerance necessitates escalating doses to achieve the same effect, tolerance to clinically relevant doses of amphetamine plateaus after the initial titration period, and "drug holidays" (i.e., temporary treatment discontinuation) are not required to prevent the development of tolerance
Data from clinical trials have been very promising on this front, but its reassuring to see that these medications are also useful in clinical settings that arent as highly controlled as clinical trials. White said future research should analyze predictors for weight loss in people with diabetes to better understand who would best respond to a GLP-1 agonist and examine changes in body weight for adults who are fully adherent to GLP-1 therapy
This effect usually resolves within the first week as the body adapts to the peptide's regenerative processes